Low macrolide resistance in Streptococcus pyogenes in Southern Argentina [1]

International Journal of Antimicrobial Agents

Volumn 25, Issue 5, 2005, Pages 450-451

  Rubinstein, Gabriela ^a,c   Amoroso, Ana M ^d   Bavdaz, Bárbara ^b   De Bunder, Sabrina ^a   Blazquez, Néstor ^a   Gutkind, Gabriel O ^d  

^a Hospital Ramon Carrillo   (Argentina)

^b Sanatorio San Carlos ^*  (Argentina)

^c Lab Hospital Privado Regional   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LINCOSAMIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG TARGETING; DRUG TRANSPORT; DRUG USE; LETTER; PHENOTYPE; POPULATION ABUNDANCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; STREPTOCOCCUS PYOGENES;

EID: 17644387510     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.01.010     Document Type: Letter

References (10)

1. J.I. Alos, B. Aracil, C. Torres, J.L. Gomez-Garces The Spanish Group for the Study of Infection in Primary Health Care Setting High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998 J Antimicrob Chemother 45 2000 605 609
2. J. Yan, H. Wu, A. Whang, H. Fu, C. Lee, and J. Wu Prevalence of polyclonal mef-A containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan J Clin Microbiol 38 2000 2475 2479
3. E.L. Palavecino, I. Riedel, and Berrios Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile Antimicrob Agents Chemother 45 2001 339 341
4. S. Martinez, A.M. Amoroso, and A. Famiglietti Genetic and phenotypic characterization of resistance to macrolides in Streptococcus pyogenes from Argentina Int J Antimicrob Agents 23 2004 95 98
5. J.J. Granizo, L. Aguilar, J. Casal, R. Dal-Re, and F. Baquero Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997) J Antimicrob Chemother 46 2000 959 964
6. H. Seppala, T. Klaukka, R. Lehtonen, E. Nenonen, P. Huovinen Finnish Study Group for Antimicrobial Resistance Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci Clin Infect Dis 21 1995 1378 1385
7. H. Seppala, and M. Skurnik A novel erythromycin resistance methylase gene (erm TR) in Streptococcus pyogenes Antimicrob Agents Chemother 42 1998 257 262
8. J. Sutcliffe, A. Tait-Kamradt, and L. Wondrack Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system Antimicrob Agents Chemother 40 1996 1817 1824
9. H. Seppala, A. Nissinen, Q. Yu, and P. Huovinen Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland J Antimicrob Chemother 32 1993 885 891
10. J. Sutcliffe, T. Grebe, A. Tait-Kamradt, and L. Wondrack Detection of erythromycin resistant determinants by PCR Antimicrob Agents Chemother 40 1996 2562 2566